Docetaxel vs paclitaxel

The incidence of peripheral sensory neuropathy in the nab-paclitaxel group was higher than that in the docetaxel group (60.76% vs 36.25%; P = 0.008), while the incidence of arthralgia was observed more frequently in the docetaxel group (57.50% vs 39.97%; P = 0.047).

anthracycline drugs such as doxorubicin, pegylated liposomal doxorubicin and epirubicin taxane drugs such as paclitaxel, docetaxel and nab-paclitaxel

Nab-paclitaxel vs sb-paclitaxel or nab-paclitaxel vs docetaxel. Since there were two types of control arm (sb-paclitaxel arm 2,3 or docetaxel arm 4,5,10), we did further subgroup analysis to see

Paclitaxel and docetaxel - Characteristics of infusion reactions. Delayed reactions - Incidence with paclitaxel - Incidence with docetaxel - Mechanisms of infusion reactions. Drug versus vehicle; Other idiosyncratic reactions - Premedication regimens. Paclitaxel; Docetaxel; Test dosing (not recommended) Retreatment after an infusion reaction

paclitaxel (Abraxane) vs docetaxel (Taxotere), in the first-line treatment of metastatic breast cancer.

Median time to progression also significantly favored the docetaxel group: 5.7 months vs 3.6 months for paclitaxel (P .0001). The overall response rate in the intent-to-treat analysis was 32% for docetaxel vs 25% for paclitaxel ( P = .10), which approached statistical significance, Dr. Ravdin said.

taxanes – such as docetaxel, paclitaxel, and nab-paclitaxel. These drugs are commonly used in combination with other chemotherapy drugs, including

Taxotere (docetaxel) vs. Taxol (paclitaxel) Why patients should use a less safe drug? When the manufacturer started marketing Taxotere (docetaxel), it widely marketed it as more potent and effective than its older counterpart Taxol (paclitaxel).

Abbreviation: HCTZ, hydrochlorothiazide. aRegimens include TC (docetaxel cyclophosphamide or paclitaxel cyclophosphamide or paclitaxel docetaxel